Search

everythinglearnresearchcommunity

for

Search:↓

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

The immune system can cause permanent skin and hair whitening by attacking pigment cells.

Injecting young pig stem cells can make old pig skin look younger and more elastic.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

CMV infection increases the risk of GvHD after bone marrow transplants.

Combining PRP and MSCs improves skin healing and structure.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Tissue engineering advancements are improving skin substitutes for better burn treatment.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

cGVHD often severely affects the skin, causing rapid aging and other issues.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Stem cell therapy improves healing and reduces pain in cutaneous radiation syndrome.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.